Cibus Insider Trading Activity | NASDAQ:CBUS

Comments

Cibus Inc Insider Trading Activity

CBUSNASDAQ

Trade with Public

$1.51

0.2519.84%

At close: Apr 10, 5:00 PM EST

$1.48

-0.03-1.99%

After Hours: Apr 10, 7:58 PM EST

Overview News Earnings Options Analyst RatingsInsider TradesShort Interest Stock Report

Cibus Insider Trading Activity | NASDAQ:CBUS | Benzinga

Track the latest Cibus insider trading activity. Stay informed on recent buys, sells, and market impact for Cibus stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Cibus Inc Insiders Doing?

At Cibus Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 1.84K shares worth $2.43K, meanwhile, insiders have report no purchases in the last 30 days.

Notable Recent Insider Buys and Sales

On March 18, 2026, Noel Sauer, the company's SR VP, RESEARCH sold 1.84K shares for 1.32 each.

Ownership Statistics for Cibus Inc

Shares Outstanding

76.173M

Shares Float

67480841.0%

Insider Shares Owned

18.165M

Insider Percentage Owned

27.5%

Institutional Shares Held

11.633M

Institutional Percentage Held

15.3%

Loading calendar...

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

CBUS Insider Trading News

PRO
Cibus Chairman Rory Riggs Interest In Purchasing Up To $10M In Public Offering Is Non-Binding And Final Offering Remains Subject To Market Conditions And Uncertainty

Benzinga Newsdesk

PRO
Cibus Announces Public Offering Of Class A Common Stock; Chairman Rory Riggs Signals Interest In Up To $10M Purchase Of Shares Of Class A Common Stock And/Or Common Stock Equivalents In This Offering

Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds,

Benzinga Newsdesk

People Also Watch

Anixa Biosciences Inc

NASDAQ:ANIX

$2.80

4.25%

Estrella Immunopharma Inc

NASDAQ:ESLA

$1.76

-4.33%

Gain Therapeutics Inc

NASDAQ:GANX

$1.78

-1.06%

Coeptis Therapeutics Holdings Inc

Inovio Pharmaceuticals Inc

NASDAQ:INO

$1.06

Sangamo Therapeutics Inc